InsiderTrades.com logo

RNXT Insider Trading

Insider Ownership Percentage: 9.13%
Insider Buying (Last 12 Months): $146,518.50
Insider Selling (Last 12 Months): $0.00

RenovoRx Insider Trading History Chart

This chart shows the insider buying and selling history at RenovoRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

RenovoRx Share Price & Price History

Current Price: $0.95
Price Change: ▲ Price Increase of +0.0456 (5.04%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for RNXT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

RenovoRx Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/24/2025Ramtin AgahInsiderBuy12,000$0.80$9,600.00756,460View SEC Filing Icon  
11/21/2025Ramtin AgahInsiderBuy10,000$0.80$8,000.00744,460View SEC Filing Icon  
8/25/2025Shaun BagaiCEOBuy5,000$0.91$4,550.00330,040View SEC Filing Icon  
8/22/2025Shaun BagaiCEOBuy5,000$0.95$4,750.00325,040View SEC Filing Icon  
6/5/2025Ramtin AgahInsiderBuy21,000$1.40$29,400.00734,460View SEC Filing Icon  
4/15/2025Ramtin AgahInsiderBuy15,000$0.90$13,500.001,113,460View SEC Filing Icon  
4/15/2025Shaun BagaiCEOBuy7,500$0.91$6,825.00320,040View SEC Filing Icon  
4/11/2025Ramtin AgahInsiderBuy20,000$0.80$16,000.001,098,460View SEC Filing Icon  
4/10/2025Ron KocakVPBuy6,500$0.79$5,135.0012,595View SEC Filing Icon  
4/9/2025Shaun BagaiCEOBuy10,000$0.83$8,300.00312,540View SEC Filing Icon  
4/8/2025Laurence MartonDirectorBuy12,050$0.85$10,242.5045,684View SEC Filing Icon  
4/8/2025Ramtin AgahInsiderBuy26,000$0.84$21,840.001,048,460View SEC Filing Icon  
4/8/2025Ron KocakVPBuy95$0.80$76.0095View SEC Filing Icon  
4/7/2025Shaun BagaiCEOBuy10,000$0.83$8,300.00302,540View SEC Filing Icon  
10/3/2023Angela NelmsCOOBuy1,100$1.05$1,155.001,100View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for RenovoRx (NASDAQ:RNXT)

3.10% of RenovoRx stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RNXT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

RenovoRx Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Citadel Advisors LLC121,341$0.15M0.0%N/A0.331%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.1,605,079$2.04M0.0%-3.5%4.380%Search for SEC Filing on Google Icon
10/31/2025AIGH Capital Management LLC2,615,193$3.32M0.9%-24.6%7.136%Search for SEC Filing on Google Icon
8/15/2025AWM Investment Company Inc.1,870,225$2.47M0.3%-18.2%5.114%Search for SEC Filing on Google Icon
8/13/2025Northwestern Mutual Wealth Management Co.74,596$98K0.0%N/A0.204%Search for SEC Filing on Google Icon
8/13/2025Corsair Capital Management L.P.95,373$0.13M0.0%-49.2%0.261%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC353,603$0.47M0.0%+9.9%0.967%Search for SEC Filing on Google Icon
5/16/2025AWM Investment Company Inc.2,285,000$2.26M0.3%N/A6.251%Search for SEC Filing on Google Icon
5/16/2025Alyeska Investment Group L.P.688,577$0.68M0.0%N/A1.884%Search for SEC Filing on Google Icon
5/16/2025ADAR1 Capital Management LLC479,883$0.48M0.1%+143.3%1.313%Search for SEC Filing on Google Icon
5/15/2025Corsair Capital Management L.P.187,700$0.19M0.0%N/A0.514%Search for SEC Filing on Google Icon
5/14/2025Stonepine Capital Management LLC278,188$0.28M0.3%N/A0.761%Search for SEC Filing on Google Icon
5/13/2025HighTower Advisors LLC40,000$40K0.0%N/A0.109%Search for SEC Filing on Google Icon
5/9/2025Chicago Partners Investment Group LLC92,356$97K0.0%N/A0.253%Search for SEC Filing on Google Icon
5/6/2025AIGH Capital Management LLC3,467,275$3.43M1.4%N/A9.486%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC37,757$49K0.0%N/A0.157%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC64,900$84K0.0%N/A0.270%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC197,250$0.25M0.1%-37.4%0.822%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC232,937$0.25M0.0%+61.9%0.971%Search for SEC Filing on Google Icon
2/9/2024Nixon Peabody Trust Co.97,165$0.22M0.0%N/A0.909%Search for SEC Filing on Google Icon
7/10/2023Level Four Advisory Services LLC15,000$34K0.0%+50.0%0.148%Search for SEC Filing on Google Icon
6/5/2023Level Four Advisory Services LLC10,000$35K0.0%N/A0.099%Search for SEC Filing on Google Icon
1/19/2023Affinity Capital Advisors LLC15,259$36K0.0%+35.6%0.168%Search for SEC Filing on Google Icon
11/10/2022Cohen Lawrence B54,121$0.16M0.1%-44.3%0.597%Search for SEC Filing on Google Icon
8/11/2022Cohen Lawrence B97,165$0.19M0.1%+79.5%1.072%Search for SEC Filing on Google Icon
8/2/2022Bank of The West975,000$1.93M0.2%N/A10.750%Search for SEC Filing on Google Icon
5/13/2022Cohen Lawrence B54,121$0.16M0.1%N/A0.599%Search for SEC Filing on Google Icon
2/3/2022Cambridge Investment Research Advisors Inc.14,400$70K0.0%-64.7%0.162%Search for SEC Filing on Google Icon
11/16/2021Schonfeld Strategic Advisors LLC20,569$0.13M0.0%N/A0.245%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Securities LLC17,944$0.11M0.0%N/A0.214%Search for SEC Filing on Google Icon
11/12/2021Board of Trustees of The Leland Stanford Junior University60,863$0.37M0.0%N/A0.726%Search for SEC Filing on Google Icon
11/2/2021Cambridge Investment Research Advisors Inc.40,850$0.25M0.0%N/A0.487%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
RenovoRx logo
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
Read More on RenovoRx

Today's Range

Now: $0.95
Low: $0.91
High: $0.96

50 Day Range

MA: $1.05
Low: $0.73
High: $1.34

52 Week Range

Now: $0.95
Low: $0.70
High: $1.69

Volume

145,604 shs

Average Volume

348,242 shs

Market Capitalization

$34.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.3

Who are the company insiders with the largest holdings of RenovoRx?

RenovoRx's top insider shareholders include:
  1. Ramtin Agah (Insider)
  2. Shaun Bagai (CEO)
  3. Laurence Marton (Director)
  4. Ron Kocak (VP)
Learn More about top insider investors at RenovoRx.

Who are the major institutional investors of RenovoRx?

RenovoRx's top institutional investors include:
  1. AIGH Capital Management LLC — 7.14%
  2. Vanguard Group Inc. — 4.38%
  3. Citadel Advisors LLC — 0.33%
Learn More about top institutional investors of RenovoRx stock.

Which major investors are selling RenovoRx stock?

During the previous quarter, RNXT stock was sold by these institutional investors:
  1. AIGH Capital Management LLC
  2. Vanguard Group Inc.

Which major investors are buying RenovoRx stock?

Within the last quarter, RNXT stock was bought by institutional investors including:
  1. Citadel Advisors LLC
During the previous year, these company insiders have bought RenovoRx stock:
  1. Ramtin Agah (Insider)
  2. Shaun Bagai (CEO)
  3. Laurence Marton (Director)
  4. Ron Kocak (VP)
Learn More investors buying RenovoRx stock.